342 related articles for article (PubMed ID: 26943968)
21. Characteristics Of acetylcholine-receptor-antibody-negative myasthenia gravis in a South African cohort.
Huda S; Woodhall MR; Vincent A; Heckmann JM
Muscle Nerve; 2016 Dec; 54(6):1023-1029. PubMed ID: 27105303
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic utility of cortactin antibodies in myasthenia gravis.
Illa I; Cortés-Vicente E; Martínez MÁ; Gallardo E
Ann N Y Acad Sci; 2018 Jan; 1412(1):90-94. PubMed ID: 29068555
[TBL] [Abstract][Full Text] [Related]
23. An update on laboratory diagnosis in myasthenia gravis.
Oger J; Frykman H
Clin Chim Acta; 2015 Sep; 449():43-8. PubMed ID: 26238187
[TBL] [Abstract][Full Text] [Related]
24. Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics.
Lazaridis K; Tzartos SJ
Front Immunol; 2020; 11():212. PubMed ID: 32117321
[TBL] [Abstract][Full Text] [Related]
25. Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis.
Nakata R; Motomura M; Masuda T; Shiraishi H; Tokuda M; Fukuda T; Ando T; Yoshimura T; Tsujihata M; Kawakami A
Eur J Neurol; 2013 Sep; 20(9):1272-6. PubMed ID: 23679930
[TBL] [Abstract][Full Text] [Related]
26. Myopathy or Myasthenia Positive for Antibodies Against MuSK, Lrp4, and Titin.
Finsterer J; Frank M
Intern Med; 2021 May; 60(9):1485. PubMed ID: 33281162
[No Abstract] [Full Text] [Related]
27. IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis.
Leite MI; Jacob S; Viegas S; Cossins J; Clover L; Morgan BP; Beeson D; Willcox N; Vincent A
Brain; 2008 Jul; 131(Pt 7):1940-52. PubMed ID: 18515870
[TBL] [Abstract][Full Text] [Related]
28. Anti-MuSK Positive Myasthenia Gravis with Anti-Lrp4 and Anti-titin Antibodies.
Yamashita R; Shimizu M; Baba K; Beck G; Kinoshita M; Okuno T; Higuchi O; Mochizuki H
Intern Med; 2021 Jan; 60(1):137-140. PubMed ID: 32830177
[TBL] [Abstract][Full Text] [Related]
29. Anti-AChR, MuSK, and LRP4 antibodies coexistence: A rare and distinct subtype of myasthenia gravis from Indian subcontinent.
Bokoliya SC; Kumar VP; Nashi S; Polavarapu K; Nalini A; Patil SA
Clin Chim Acta; 2018 Nov; 486():34-35. PubMed ID: 30006288
[TBL] [Abstract][Full Text] [Related]
30. Electrophysiological findings in patients with low density lipoprotein receptor related protein 4 positive myasthenia gravis.
Nikolic AV; Bojic SD; Rakocevic Stojanovic VM; Basta IZ; Lavrnic DV
Eur J Neurol; 2016 Nov; 23(11):1635-1641. PubMed ID: 27415961
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic and clinical classification of autoimmune myasthenia gravis.
Berrih-Aknin S; Frenkian-Cuvelier M; Eymard B
J Autoimmun; 2014; 48-49():143-8. PubMed ID: 24530233
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of myasthenia gravis and associated autoantibodies in paraneoplastic pemphigus and their correlations with symptoms and prognosis.
Wang R; Li J; Wang M; Hao H; Chen X; Li R; Zhu X
Br J Dermatol; 2015 Apr; 172(4):968-75. PubMed ID: 25388377
[TBL] [Abstract][Full Text] [Related]
33. Immunostick ELISA for rapid and easy diagnosis of myasthenia gravis.
Trakas N; Tzartos SJ
J Immunol Methods; 2018 Sep; 460():107-112. PubMed ID: 30056940
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic use of autoantibodies in myasthenia gravis.
Leite MI; Waters P; Vincent A
Autoimmunity; 2010 Aug; 43(5-6):371-9. PubMed ID: 20380582
[TBL] [Abstract][Full Text] [Related]
35. Autoantibodies in acquired myasthenia gravis: Clinical phenotype and immunological correlation.
Nagappa M; Mahadevan A; Gangadhar Y; Patil SA; Bokolia S; Bindu PS; Sinha S; Taly AB
Acta Neurol Scand; 2019 May; 139(5):428-437. PubMed ID: 30693486
[TBL] [Abstract][Full Text] [Related]
36. Anti-LRP4 autoantibodies in Chinese patients with myasthenia gravis.
Li Y; Zhang Y; Cai G; He D; Dai Q; Xu Z; Chu L
Muscle Nerve; 2017 Nov; 56(5):938-942. PubMed ID: 28120340
[TBL] [Abstract][Full Text] [Related]
37. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
Caress JB; Hunt CH; Batish SD
Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
[TBL] [Abstract][Full Text] [Related]
38. Seronegative myasthenia gravis.
Vincent A; McConville J; Farrugia ME; Newsom-Davis J
Semin Neurol; 2004 Mar; 24(1):125-33. PubMed ID: 15229799
[TBL] [Abstract][Full Text] [Related]
39. Detection of Autoantibodies Against the Acetylcholine Receptor, Evaluation of Commercially Available Methodologies: Fixed Cell-Based Assay, Radioimmunoprecipitation Assay and Enzyme-Linked Immunosorbent Assay1.
Diogenes L; Dellavance A; Baldo DC; Gozzi-Silva SC; Gomes K; Prado MS; Andrade LEC; Keppeke GD
J Neuromuscul Dis; 2024; 11(3):613-623. PubMed ID: 38578899
[TBL] [Abstract][Full Text] [Related]
40. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies.
Romi F; Skeie GO; Aarli JA; Gilhus NE
Arch Neurol; 2000 Nov; 57(11):1596-600. PubMed ID: 11074791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
